|
FAM115A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.12419962228216E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.16800003002737E-09 |
| Normal-vs-Stage2 |
2.741900E-02 |
| Normal-vs-Stage3 |
1.16339999967074E-07 |
| Normal-vs-Stage4 |
4.26890001126168E-09 |
| Stage1-vs-Stage2 |
4.965900E-02 |
| Stage1-vs-Stage3 |
4.190000E-01 |
| Stage1-vs-Stage4 |
2.957800E-02 |
| Stage2-vs-Stage3 |
2.256400E-02 |
| Stage2-vs-Stage4 |
2.764500E-03 |
| Stage3-vs-Stage4 |
2.448000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.4830003891575E-10 |
| Normal-vs-AfricanAmerican |
5.9829999999983E-05 |
| Normal-vs-Asian |
3.85170000005708E-07 |
| Caucasian-vs-AfricanAmerican |
8.196600E-01 |
| Caucasian-vs-Asian |
5.002000E-01 |
| AfricanAmerican-vs-Asian |
4.645400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.20880000453738E-08 |
| Normal-vs-Female |
6.669100049983E-09 |
| Male-vs-Female |
4.156500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.56399999956736E-07 |
| Normal-vs-Age(41-60Yrs) |
1.77869999951064E-07 |
| Normal-vs-Age(61-80Yrs) |
4.64380000009257E-07 |
| Normal-vs-Age(81-100Yrs) |
8.540300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.792800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.142000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.264000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.149200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.160000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.291600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.838600E-03 |
| Classical-VS-Follicular |
2.655600E-01 |
| Classical-VS-Other |
1.064430E-01 |
| Classical-VS-Normal |
6.58799999997406E-07 |
| Tall-VS-Follicular |
4.095500E-03 |
| Tall-VS-Other |
4.580000E-01 |
| Tall-VS-Normal |
3.64050001255833E-09 |
| Follicular-VS-Other |
2.012300E-02 |
| Follicular-VS-Normal |
6.812700E-04 |
| Other-VS-Normal |
1.404090E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.32980000011607E-07 |
| Normal-vs-N1 |
4.05369999789684E-08 |
| N0-vs-N1 |
4.435700E-02 |
|
|
